23 May 2013
Keywords: pdl, zamyl, mixed, results, phase, iii, acute
Article | 10 December 2001
Protein Design Labs has reported what it says are positive results froma Phase III trial of its candidate ther_apy ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 July 2001
22 May 2013
© 2013 thepharmaletter.com